Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-03

Clinical Trial Update: Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO). [Phase 2]

View source ↗

Summary

A Phase 2 study of velusetrag for chronic intestinal pseudo-obstruction has completed. Results have been posted on 2025-08-03.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Velusetrag (Velusetrag)

Snippet

Sponsor: Alfasigma S.p.A. | Conditions: Chronic Intestinal Pseudo-obstruction | Phase 2 | Status: COMPLETED | Results posted: 2025-08-03